Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
SRZN Surrozen
0.770+0.026+3.49%
Close
02/08 16:00 ET
0.779+0.009+1.14%
Post Mkt Price 02/08 19:16 ET
High
0.780
Open
0.760
Turnover
66.52K
Low
0.730
Pre Close
0.744
Volume
87.97K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Short Interest in Surrozen, Inc. (NASDAQ:SRZN) Drops By 18.7%
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totalling 227,300 shares, a decline of 18
Surrozen, Inc. (NASDAQ:SRZN) Short Interest Down 18.7% in January
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 227,300 shares,
Surrozen, Inc. (NASDAQ:SRZN) Sees Significant Decline in Short Interest
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the target of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 227,300 shares, a de
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersGenetic Technologies (NASDAQ:GENE) stock increased by 7.1% to $1.01 during Tuesday's after-market session. The market value of their outstanding shares is at $15.5 million. Nymox Pharmaceutical
Financial Review: Jasper Therapeutics (NASDAQ:JSPR) and Surrozen (NASDAQ:SRZN)
Jasper Therapeutics (NASDAQ:JSPR – Get Rating) and Surrozen (NASDAQ:SRZN – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies base
Surrozen, Inc. (NASDAQ:SRZN) Short Interest Update
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the target of a significant growth in short interest in December. As of December 30th, there was short interest totalling 279,700 shares, a growth of 18
Surrozen to Present at the 41st Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. ("Surrozen" or the "Company") (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the W
Short Interest in Surrozen, Inc. (NASDAQ:SRZN) Drops By 20.6%
Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the recipient of a large decrease in short interest in December. As of December 15th, there was short interest totalling 97,000 shares, a decrease of 20
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers180 Life Sciences (NASDAQ:ATNF) stock rose 75.8% to $2.18 during Tuesday's pre-market session. The company's market cap stands at $4.4 million. HTG Molecular Diagnostics (NASDAQ:HTGM) stock mov
Top Premarket Decliners
07:50 AM EST, 12/27/2022 (MT Newswires) -- Tuesday Morning (TUEM) slumped 44% after the company said it will voluntarily delist its stock from the Nasdaq Capital Market. Surrozen (SRZN) shares tumble
Company Overview
More
Surrozen, Inc. is a preclinical stage biotechnology company, which engages in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. It is also focused on developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and certain neurological disorders. The company was founded on August 12, 2015 and is headquartered in South San Francisco, CA.
CEO： Mr. Craig C. Parker
Market： NASDAQ
Listing Date： 08/12/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet